Viewing Study NCT03736720


Ignite Creation Date: 2025-12-25 @ 4:15 AM
Ignite Modification Date: 2026-02-26 @ 3:17 AM
Study NCT ID: NCT03736720
Status: TERMINATED
Last Update Posted: 2025-01-30
First Post: 2018-11-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Liposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic Origin
Sponsor: Roswell Park Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Advanced Digestive System Neuroendocrine Carcinoma View
None Locally Advanced Pancreatic Neuroendocrine Carcinoma View
None Metastatic Digestive System Neuroendocrine Carcinoma View
None Metastatic Pancreatic Neuroendocrine Carcinoma View
None Refractory Digestive System Neuroendocrine Carcinoma View
None Refractory Pancreatic Neuroendocrine Carcinoma View
None Unresectable Digestive System Neuroendocrine Carcinoma View
None Unresectable Pancreatic Neuroendocrine Carcinoma View
Keywords: